GAM Systematic’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-4,326
Closed -$385K 675
2017
Q1
$385K Buy
4,326
+2,459
+132% +$202K 0.08% 410
2016
Q4
$132K Sell
1,867
-8,414
-82% -$627K 0.03% 510
2016
Q3
$812K Buy
10,281
+5,452
+113% +$465K 0.17% 253
2016
Q2
$438K Buy
4,829
+2,301
+91% +$195K 0.11% 359
2016
Q1
$215K Buy
+2,528
New +$188K 0.06% 464
2015
Q1
Sell
-2,113
Closed -$212K 424
2014
Q4
$212K Buy
+2,113
New +$211K 0.04% 331

Other funds holding MJN

GAM Systematic's MJN Position: Q2 2017 in Review

GAM Systematic sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 4,326 shares — an estimated $385K sold.

GAM Systematic first reported a position in MJN in Q4 2014 and held it in 6 quarters. The position peaked at $812K in Q3 2016. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • GAM Systematic reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • GAM Systematic sold 4,326 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $385K.
  • GAM Systematic first reported a position in Mead Johnson Nutrition Company in Q4 2014 and held it in 6 quarters.
  • GAM Systematic's Mead Johnson Nutrition Company position peaked at $812K in Q3 2016.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on GAM Systematic's 13F filing for Q2 2017, filed 14 Aug 2017.